5-(4-Methoxyphenyl)-4-(3-methoxy-4,5-methylenedioxyphenyl)-1H-pyrazol-3-amine
Compound with spectra: 1 NMR, and 1 MS (GC)
| SpectraBase Compound ID | Gz6HOm6KR5V |
|---|---|
| InChI | InChI=1S/C18H17N3O4/c1-22-12-5-3-10(4-6-12)16-15(18(19)21-20-16)11-7-13(23-2)17-14(8-11)24-9-25-17/h3-8H,9H2,1-2H3,(H3,19,20,21) |
| InChIKey | GIOSRJQJUKBUHY-UHFFFAOYSA-N |
| Mol Weight | 339.35 g/mol |
| Molecular Formula | C18H17N3O4 |
| Exact Mass | 339.121906 g/mol |
| Copyright | Copyright © 2020-2024 John Wiley & Sons, Inc. All Rights Reserved. |
|---|---|
| Source of Spectrum | G4-76-1490-14b |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|
5-(3,4-DIMETHOXYPHENYL)-4-(3,4,5-TRIMETHOXYPHENYL)-ISOXAZOLE
phenol, 2-[4-(4-bromophenyl)-5-methyl-1H-pyrazol-3-yl]-5-[2-(1-piperidinyl)ethoxy]-
5-(4-Ethylphenyl)-3,4-bis(4-methoxyphenyl)-1-methyl-1H-pyrazole
3,4-Bis(4-methoxyphenyl)-1-methyl-5-p-tolyl-1H-pyrazole
1H-imidazole, 2-(7-methoxy-1,3-benzodioxol-5-yl)-4,5-di(2-thienyl)-
acetic acid, [3-hydroxy-4-(5-methyl-4-phenyl-1H-pyrazol-3-yl)phenoxy]-, hydrazide
4,5-bis(3',4'-Dimethoxyphenyl)-2-[2"-(hydroxymethyl)ethyl]-pyridine
4-(3',4'-Dimethoxyphenyl)-5-(p-methoxyphenyl)-2-[3"-(hydroxycarbonyl)propyl]-pyridine
2,3-TRANS-2-METHYL-3-[(3'-HYDROXYL-4',5'-DIMETHOXYPHENYL)-(5''-METHOXY-3'',4''-METHYLENEDIOXYPHENYL)-METHYL]-BUTYROLACTONE
3-(3,5-Dimethoxyphenyl)-4-(4-methoxyphenyl)-1H-pyrrole-2-carboxylic acid methyl ester
| Title | Journal or Book | Year |
|---|---|---|
| cis-Restricted 3-Aminopyrazole Analogues of Combretastatins: Synthesis from Plant Polyalkoxybenzenes and Biological Evaluation in the Cytotoxicity and Phenotypic Sea Urchin Embryo Assays | Journal of Natural Products | 2013 |
This compound is available in the following databases:
Wiley Registry of Mass Spectral Data 2023
Author: Wiley
The foundation library for any analytical laboratory running mass spectrometry, the Wiley Registry provides the broadest coverage available in any mass spectral library Learn more.